The global health investor and public health advocate expresses concern over the re-emergence of a smallpox-like disease called mpox, which has caused thousands of cases and hundreds of deaths. Despite available vaccines and treatments, limited resources and bureaucratic challenges hinder widespread access. The global response to mpox has been reactive rather than proactive, with efforts to combat the disease only escalating after it spread to multiple countries. Collaborative efforts are needed to address the growing threat of mpox, as well as to invest in new vaccines and treatments to ensure a rapid global response. The situation highlights the importance of timely mobilization of resources to prevent public health emergencies and future pandemics.
Source link
Controlling mpox is an urgent goal
